Naloxone
ADVERTISEMENT
- Molecular formula
- C19H21NO2
- CAS Number
- 357-08-4
- IUPAC Name
- N,N-diethyl-2-[3-(3-pyridyl)isoxazol-5-yl]ethanamine
- Molecular Weight
- 327.37g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2860g/cm3
Identification
Interesting facts
Interesting Facts about N,N-Diethyl-2-[3-(3-pyridyl)isoxazol-5-yl]ethanamine
N,N-Diethyl-2-[3-(3-pyridyl)isoxazol-5-yl]ethanamine is a fascinating compound with a unique structure and potential applications:
- Pharmacological Potential: This compound belongs to a class of molecules known for their neuropharmacological properties. Research indicates that derivatives of isoxazole are often investigated for their ability to modulate neurotransmitter systems.
- Structural Complexity: The incorporation of a pyridine ring introduces intriguing electronic properties that can influence the biological activity of the compound. Pyridine is known for its aromaticity and ability to participate in hydrogen bonding, which may enhance the binding of the molecule to its targets.
- Isomer Significance: The isoxazole moiety is notable in medicinal chemistry as it serves as a scaffold for various drug candidates. Its structural features can lead to varied pharmacokinetic and pharmacodynamic profiles.
- Research and Development: Ongoing studies may evaluate the compound for therapeutic applications, particularly in contexts such as anxiety and depression, where modulation of neurotransmitters like serotonin and norepinephrine is critical.
- Structure-Activity Relationship (SAR): The exploration of N,N-diethyl-2-[3-(3-pyridyl)isoxazol-5-yl]ethanamine contributes to our understanding of SAR, which is vital for the design of more effective pharmacological agents.
In conclusion, the complex interplay between the various functional groups in N,N-diethyl-2-[3-(3-pyridyl)isoxazol-5-yl]ethanamine highlights the importance of structural nuances in drug discovery. As research advances, this compound may lead to exciting developments in therapeutic solutions.